| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Oct 24 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.84 | 36,404 | 103.39 k | 1,131,988 |
| 16 May 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.9 | 344,828 | 1.00 mm | 1,164,418 |
| 15 May 24 | PRGO Perrigo | Ordinary Shares | Payment of exercise | Dispose F | No | No | 30.22 | 4,207 | 127.14 k | 20,262 |
| 15 May 24 | PRGO Perrigo | Ordinary Shares | Option exercise | Acquire M | No | No | 30.22 | 8,764 | 264.85 k | 24,469 |
| 15 May 24 | PRGO Perrigo | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 8,764 | 0.00 | 0 |
| 14 May 24 | PRGO Perrigo | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 9,904 | 0.00 | 9,904 |
| 30 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.595 | 190 | 683.05 | 819,590 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 29,400 | 0.00 | 819,400 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.2 | 103,939 | 332.60 k | 103,939 |
